Traditional Chinese medicine retailer Eu Yan Sang has requested a suspension of trading in its shares on the Singapore Exchange, with a delist on October 7.

This spells an end to the group’s 16 years on the SGX main board.

The move follows a privatisation bid for the company by a consortium led by a UOB-backed fund, a Temasek Holdings unit and Eu Yan Sang International’s group CEO Richard Eu. The consortium offered S60 cents (US 44c) cash for each share it does not own, an offer that has just expired. This put a value of about S$269 million (US$196 million) on Eu Yan Sang.

Eu Yan Sang launched in Malaysia in 1879, expanding to more than 250 outlets in China, Hong Kong, Macau and Australia.